Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 4Brain Neoplasms 4Glioma 3Glioblastoma 3Carcinoma, Hepatocellular 3Neoplasms 2Head and Neck Neoplasms 2Skin Neoplasms 1Sarcoma 1Neoplasm Metastasis 1Meningioma 1Melanoma 1Liver Cirrhosis 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1Astrocytoma 1

Interventions

Ultrasonography 3Tomography, X-Ray Computed 2Colonoscopy 2tremelimumab 1lenvatinib 1fluoromisonidazole 1epigallocatechin gallate 1durvalumab 1babao dan 1Weights and Measures 1Vitamin B 6 1Tomography 1Tidal Volume 1Surgical Procedures, Operative 1Standard of Care 1Shadowing Technique, Histology 1Radiotherapy 1Radiomics 1Probiotics 1Preoperative Exercise 1Positron-Emission Tomography 1Portasystemic Shunt, Transjugular Intrahepatic 1Population Groups 1Plasmapheresis 1Oxaliplatin 1Medical History Taking 1Mebendazole 1Liquid Biopsy 1Introns 1Injections 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Liver Cirrhosis × fluoromisonidazole × Clear all
NCT02695628 2024-01-31

[18F]FMISO PET/CT After Transcatheter Arterial Embolization in Imaging Tumors in Patients With Liver Cancer

Stanford University

Phase 2 Completed
5 enrolled 8 charts
Gastrointestinal

Carcinoma, Hepatocellular, Liver Cirrhosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡